Tawasapon Thambamroong

ORCID: 0000-0001-6066-4253
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nutrition and Health in Aging
  • Testicular diseases and treatments
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Liver Diseases and Immunity
  • Lung Cancer Treatments and Mutations
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Lymphoma Diagnosis and Treatment
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Curcumin's Biomedical Applications
  • Mesenchymal stem cell research
  • Radiopharmaceutical Chemistry and Applications
  • Retinoids in leukemia and cellular processes
  • HER2/EGFR in Cancer Research
  • Ovarian cancer diagnosis and treatment
  • Drug-Induced Adverse Reactions
  • Chemotherapy-related skin toxicity
  • Cancer, Hypoxia, and Metabolism
  • Monoclonal and Polyclonal Antibodies Research
  • Gallbladder and Bile Duct Disorders
  • Lung Cancer Diagnosis and Treatment
  • Cell Adhesion Molecules Research

Phramongkutklao Hospital
2021-2025

Phramongkutklao College of Medicine
2025

Nakhon Pathom Rajabhat University
2022

607 Background: Currently, durvalumab plus gemcitabine and cisplatin is a standard of care for patients with advanced biliary tract cancer (BTC). We aimed to evaluate efficacy tolerability in real world experience Thailand where there high incidence liver-fluke related cholangiocarcinoma (CCA). Methods: This an observation study BTC participating the early access program since August 2023. Data were collected analyzed toxicity. Results: Fifty participated 14 centers across Thailand. Median...

10.1200/jco.2025.43.4_suppl.607 article EN Journal of Clinical Oncology 2025-01-27

Background. Cancer anorexia-cachexia syndrome (CAS) is a significant comorbidity among all patients with cancer, increasing the mortality rate. Almost head and neck cancer experience this syndrome. CAS causes increased energy expenditure by systemic inflammation decreasing consumption due to anorexia. It leads skeleton muscle breakdown reduces quality of life. Nutritional interventions primary treatment are mainstays manage situation. However, vicious cycle persist, especially in where...

10.1155/2022/5425619 article EN cc-by Journal of Nutrition and Metabolism 2022-06-02

e24051 Background: The CurChexia study, NCT04208334, is a phase IIa randomized control trial. study demonstrates the benefits of adding 4,000 mg curcumin to standard nutritional intervention. This addition helps increase muscle mass and delay decrease in other body composition parameters. However, clinicians require treatment that maintains or improves quality life (QoL) head neck cancer patients. In this report, we present QoL data. Methods: Patients participating were required complete...

10.1200/jco.2024.42.16_suppl.e24051 article EN Journal of Clinical Oncology 2024-06-01

Human epidermal growth factor receptor 2 (HER-2) is the prognostic and predictive biomarker for breast cancer found in a quarter of all cases. Precise testing HER-2 will impact treatment response.Based on updated American Society Clinical Oncology/College Pathologists (ASCO/CAP) guidelines, we report 141 cases positive concordance rate between IHC stain dual-probe ISH classified equivocal (2+) (3+) groups Nakhon Pathom Hospital, Thailand. Our study showed statistical significance...

10.3332/ecancer.2022.1370 article EN cc-by ecancermedicalscience 2022-03-31

Hepatoid adenocarcinoma (HAC) is a rare tumour that produces an alpha-fetoprotein (AFP) mimicking hepatocellular carcinoma (HCC). Adrenal HAC exceedingly rare. Here we report extremely high AFP-producing adrenal HAC, the first case in Thailand. A 47-year-old man presented with left flank pain and weight loss for 2 months. palpably huge mass was observed on physical examination. CT revealed 7 cm enhanced involving gland multiple contrast-enhanced hypodense masses both liver lobes. The largest...

10.1136/bcr-2020-239830 article EN BMJ Case Reports 2021-07-01
Coming Soon ...